Why haven’t we cured cancer? IET EngTalks: Future Science

Despite a century of incredible breakthroughs, cancer patient survival rates are still quoted in terms of 3 or 5 years and the impact of new treatments is so varied.

Could we design, manufacture and deliver ‘stimuli-responsive’ particles directly to the target site?

Oxford University’s Professor Eleanor Stride believes we can. In this year’s first Future Science EngTalk, she’ll introduce her work with ‘microbubbles’, the challenges of new drug delivery strategies and their potential for improving treatment of major diseases such as cancer or stroke.

First up, introducing Eleanor, will be our 10-minute insight speaker, Dr Jack Kreindler.

Founder of The Centre for Health and Human Performance, this is a man who wants to bring Artificial Intelligence into medical practice.